MA-NEURALA
24.3.2021 14:02:15 CET | Business Wire | Press release
Today, Neurala , the leader in vision AI software, announced a collaboration with FLIR Systems Inc. to deliver a full software and hardware stack AI-based industrial imaging solution. Neurala’s vision AI software unlocks the power of deep learning with no-AI-expertise-required, and now supports the creation of neural networks that can be deployed directly onto FLIR Firefly DL cameras. As a leader in machine vision cameras, FLIR Firefly DL cameras are remarkably compact with built-in inference on the edge capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210324005235/en/
Through the collaboration, Neurala and FLIR are delivering a faster, more cost-effective entry point for customers looking to deploy deep learning on the production line. This comes at a time when manufacturers are focused on AI and automation to provide flexibility to cope with production constraints, supply chain disruptions, and scattered workforce availability.
The new solution allows customers to rapidly create deep learning models using Neurala’s Brain Builder on the VIA platform with little data and no AI expertise. These models can be directly uploaded to a FLIR Firefly DL camera using the free FLIR Spinnaker SDK. As a result, neural networks can be deployed for a wide variety of applications, including printed circuit board (PCB) inspection, detection of foreign objects, identification of surface level metal defects and product uniformity issues. With the ability to deploy directly onto the compact FLIR Firefly DL camera, an intelligent, automated inspection point can be placed practically anywhere in-line and quickly reconfigured for new applications.
“The rise of Industry 4.0 has challenged manufacturers to rethink the tools and systems they are using as part of their workflow. With cameras and sensors gathering product data and analyzing the overall health of industrial equipment, manufacturers have realized the power of AI to draw actionable insights from this data,” said Max Versace, CEO and co-founder of Neurala. “We are thrilled to collaborate with FLIR to enable customers to capitalize on the data their machines are collecting as they look to further automate their manufacturing processes.”
“Being one of the world’s first machine vision manufacturers with an inference on the edge solution, we are constantly looking for ways to help our customers stay at the cutting edge,” said Sadiq Panjwani, Vice President, Components Business, FLIR Systems. “Our collaboration with Neurala on a simplified and accessible full-stack deep learning solution is another step in that direction, bringing customers the advanced machine vision techniques required for today’s highly automated industrial environments.”
To learn more about Neurala’s Vision AI software for FLIR Firefly DL machine vision cameras, click here .
About Neurala
Neurala is a pioneer in vision AI software. On a mission to make AI more applicable and useful in real-world applications, Neurala helps industrial companies improve their quality inspection process, with technology that dramatically reduces the time, cost and skills required to build and maintain production-quality custom vision AI solutions. Founded in 2006, Neurala’s research team invented Lifelong-DNN™ (L-DNN) technology, which lowers the data requirements for AI model development and enables continuous learning in the cloud or at the edge.
Follow Neurala on Twitter (@Neurala) and on Facebook , YouTube and LinkedIn , or subscribe to our blog to receive more information about the latest developments at Neurala.
For a more in depth look at Neurala’s vision AI software, request a virtual demo .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210324005235/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
